2000, ISBN: 0792361695, Lieferbar binnen 4-6 Wochen Versandkosten:Versandkostenfrei innerhalb der BRD
Internationaler Buchtitel. In englischer Sprache. Verlag: SPRINGER VERLAG GMBH, 320 Seiten, [GR: 16940 - HC/Innere Medizin/Chirurgie], [SW: - Medical / Nursing], Gebunden, Klappentext: T… Mehr…
Buchgeier.com Lieferbar binnen 4-6 Wochen (Besorgungstitel) Versandkosten:Versandkostenfrei innerhalb der BRD Details... |
ISBN: 9780792361695
The emergence of multidrug-resistant tuberculosis (MDRTB) threatens TB control programs worldwide. Outbreaks of MDRTB in the United States grabbed the attention of the medical community a… Mehr…
Indigo.ca Versandkosten:zzgl. Versandkosten Details... |
2000, ISBN: 0792361695
[EAN: 9780792361695], Used, good, [PU: Springer], Good condition is defined as: a copy that has been read but remains in clean condition. All of the pages are intact and the cover is inta… Mehr…
AbeBooks.com WeBuyBooks, Rossendale, LANCS, United Kingdom [50604927] [Rating: 5 (of 5)] NOT NEW BOOK. Versandkosten: EUR 3.33 Details... |
Multidrug-Resistant Tuberculosis (Resurgent and Emerging Infectious Diseases) - gebunden oder broschiert
ISBN: 0792361695
[EAN: 9780792361695], New book, [PU: Kluwer Academic / Plenum Publishers, Book], Medical|Immunology, Medical|Infectious Diseases, Medical|Pulmonary & Thoracic Medicine, Usually Dispatched… Mehr…
AbeBooks.com New Book Sale, London, United Kingdom [52953497] [Rating: 5 (of 5)] NEW BOOK. Versandkosten: EUR 20.04 Details... |
2000, ISBN: 9780792361695
Springer, 2000-07-15. Good., Springer, 2000-07-15
Biblio.co.uk |
2000, ISBN: 0792361695, Lieferbar binnen 4-6 Wochen Versandkosten:Versandkostenfrei innerhalb der BRD
Internationaler Buchtitel. In englischer Sprache. Verlag: SPRINGER VERLAG GMBH, 320 Seiten, [GR: 16940 - HC/Innere Medizin/Chirurgie], [SW: - Medical / Nursing], Gebunden, Klappentext: T… Mehr…
ISBN: 9780792361695
The emergence of multidrug-resistant tuberculosis (MDRTB) threatens TB control programs worldwide. Outbreaks of MDRTB in the United States grabbed the attention of the medical community a… Mehr…
2000
ISBN: 0792361695
[EAN: 9780792361695], Used, good, [PU: Springer], Good condition is defined as: a copy that has been read but remains in clean condition. All of the pages are intact and the cover is inta… Mehr…
Multidrug-Resistant Tuberculosis (Resurgent and Emerging Infectious Diseases) - gebunden oder broschiert
ISBN: 0792361695
[EAN: 9780792361695], New book, [PU: Kluwer Academic / Plenum Publishers, Book], Medical|Immunology, Medical|Infectious Diseases, Medical|Pulmonary & Thoracic Medicine, Usually Dispatched… Mehr…
2000, ISBN: 9780792361695
Springer, 2000-07-15. Good., Springer, 2000-07-15
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Multidrug-Resistant Tuberculosis
EAN (ISBN-13): 9780792361695
ISBN (ISBN-10): 0792361695
Gebundene Ausgabe
Erscheinungsjahr: 2000
Herausgeber: SPRINGER VERLAG GMBH
320 Seiten
Sprache: eng/Englisch
Buch in der Datenbank seit 2008-02-27T19:43:26+01:00 (Berlin)
Detailseite zuletzt geändert am 2019-07-23T21:48:42+02:00 (Berlin)
ISBN/EAN: 9780792361695
ISBN - alternative Schreibweisen:
0-7923-6169-5, 978-0-7923-6169-5
Daten vom Verlag:
Autor/in: I. Bastian; F. Portaels
Titel: Resurgent and Emerging Infectious Diseases; Multidrug-resistant Tuberculosis
Verlag: Springer Netherland
312 Seiten
Erscheinungsjahr: 2000-06-30
Gewicht: 0,646 kg
Sprache: Englisch
85,55 € (DE)
87,95 € (AT)
106,50 CHF (CH)
Not available (reason unspecified)
BB; GB; Hardcover, Softcover / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Research; BC
1. Introduction: Multidrug-resistant tuberculosis: past, present and future; I. Bastian, F. Portaels. 2. The epidemiology of multidrug-resistant tuberculosis in the United States and other established market economies; M. Moore, E. McCray, I.M. Onorato. 3. Epidemiology of multidrug-resistant tuberculosis in low- and middle-income countries; M.A. Espinal. 4. The interaction of human immunodeficiency virus and multidrug-resistant tuberculosis; E. McCray, I.M. Onorato. 5. Clinical mismanagement and other factors producing antituberculosis drug resistance; A. Pablos-Mendez, K. Lessnau. 6. The molecular mechanisms of drug resistance in mycobacterium tuberculosis; H.E. Takiff. 7. DOTS and multidrug-resistant tuberculosis; M.C. Raviglione. 8.Conventional methods for antimicrobial susceptibility testing of mycobacterium tuberculosis; L. Heifets. 9. Novel rapid antimicrobial susceptibility tests for mycobacterium tuberculosis; J.C. Palomino. 10. Pharmacology of the second-line antituberculosis drugs; C.A. Peloquin, B. Auclair. 11. Treatment of multidrug-resistant tuberculosis; M.D. Iseman, G.A. Huitt. 12. Treatment of multidrug resistant tuberculosis in developing countries; J. Crofton, A. van Deun. 13. Treatment outcome of multidrug-resistant tuberculosis; E.E. Telzak. 14. Chemoprophylaxis and BCG in contacts of multidrug resistant tuberculosis; R.A. Stapledon, R. Lumb, I.S. Lim. 15. Multidrug-resistant tuberculosis and the health care worker; D.M. Weinstock, K.A. Sepkowitz. 16. The development of new chemotherapeutics for multidrug-resistant tuberculosis; C.E. Barry. 17. Population dynamics and control of multidrug-resistant tuberculosis; C. Dye, B.G. Williams. 18. Administrative, engineering, and personal protective measures for controlling mycobacterium tuberculosis; C. Richards, W.R. Jarvis. 19. Making DOTS plus work; P.E. Farmer, S.S. Shin, J. Bayona, J.Y. Kim, J.J. Furin, J.G. Brenner.< zum Archiv...